"Anti-Anxiety Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
| Descriptor ID |
D014151
|
| MeSH Number(s) |
D27.505.696.277.950.015 D27.505.954.427.210.950.015 D27.505.954.427.700.872.015
|
| Concept/Terms |
Anti-Anxiety Agents- Anti-Anxiety Agents
- Agents, Anti-Anxiety
- Anti Anxiety Agents
- Anxiolytic Agents
- Agents, Anxiolytic
- Tranquilizing Agents, Minor
- Agents, Minor Tranquilizing
- Minor Tranquilizing Agents
- Tranquillizing Agents, Minor
- Agents, Minor Tranquillizing
- Minor Tranquillizing Agents
- Anti-Anxiety Drugs
- Anti Anxiety Drugs
- Drugs, Anti-Anxiety
- Anxiolytics
Anti-Anxiety Effect- Anti-Anxiety Effect
- Anti Anxiety Effect
- Effect, Anti-Anxiety
- Anxiolytic Effects
- Effects, Anxiolytic
- Antianxiety Effects
- Effects, Antianxiety
- Anxiolytic Effect
- Effect, Anxiolytic
- Anti-Anxiety Effects
- Anti Anxiety Effects
- Effects, Anti-Anxiety
- Antianxiety Effect
- Effect, Antianxiety
|
Below are MeSH descriptors whose meaning is more general than "Anti-Anxiety Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Anxiety Agents".
This graph shows the total number of publications written about "Anti-Anxiety Agents" by people in this website by year, and whether "Anti-Anxiety Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Anxiety Agents" by people in Profiles.
-
Pardo-Garc?a TR, Yusif-Rodriguez N, Yudowski G, Maldonado-Vlaar CS. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats. Neurosci Lett. 2020 07 27; 732:135023.
-
Hassanzadah M, Bitar AH, Khanfar NM, Khasawneh FT, Lutfy K, Shankar GS. A retrospective cohort study of the prevalence of anxiety and agitation in schizophrenic smokers and the unmet needs of smoking cessation programs. Medicine (Baltimore). 2019 Oct; 98(40):e17375.
-
Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019 03; 118:18-26.
-
Burke SL, Hu T, Spadola CE, Li T, Naseh M, Burgess A, Cadet T. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications. Sleep Med. 2018 12; 52:168-176.
-
Wang ZJ, Heinbockel T. Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases. Molecules. 2018 May 02; 23(5).
-
Musey PI, Lee JA, Hall CA, Kline JA. Anxiety about anxiety: a survey of emergency department provider beliefs and practices regarding anxiety-associated low risk chest pain. BMC Emerg Med. 2018 03 14; 18(1):10.
-
Burke SL, O'Driscoll J, Alcide A, Li T. Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Int J Geriatr Psychiatry. 2017 12; 32(12):1312-1321.
-
Torres-Hern?ndez BA, Col?n LR, Rosa-Falero C, Torrado A, Miscalichi N, Ort?z JG, Gonz?lez-Sep?lveda L, P?rez-R?os N, Su?rez-P?rez E, Bradsher JN, Behra M. Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract. Psychopharmacology (Berl). 2016 07; 233(13):2533-47.
-
Del Valle-Mojica LM, Ort?z JG. Anxiolytic properties of Valeriana officinalis in the zebrafish: a possible role for metabotropic glutamate receptors. Planta Med. 2012 Nov; 78(16):1719-24.
-
Del Rosario A, McDermott MM, Panee J. Effects of a high-fat diet and bamboo extract supplement on anxiety- and depression-like neurobehaviours in mice. Br J Nutr. 2012 Oct; 108(7):1143-9.